tiprankstipranks
Theralase Technologies (TSE:TLT)
TSXV:TLT

Theralase Technologies (TLT) Income Statement

69 Followers

Theralase Technologies Income Statement

Last quarter (Q4 2023), Theralase Technologies's total revenue was C$―, a decrease of -100.00% from the same quarter last year. In Q4, Theralase Technologies's net income was C$―. See Theralase Technologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 706.70KC$ 1.07MC$ 1.14MC$ 780.64KC$ 929.12KC$ 964.05K
Cost of Revenue
C$ 363.88KC$ 508.17KC$ 510.39KC$ 470.70KC$ 659.44KC$ 903.30K
Gross Profit
C$ 342.81KC$ 562.13KC$ 628.17KC$ 309.94KC$ 269.68KC$ 60.76K
Operating Expense
C$ 3.94MC$ 5.16MC$ 5.86MC$ 4.85MC$ 5.97MC$ 7.48M
Operating Income
C$ -3.59MC$ -4.59MC$ -5.23MC$ -4.54MC$ -5.70MC$ -7.42M
Net Non Operating Interest Income Expense
C$ 13.35KC$ 19.41KC$ 9.41KC$ -17.32KC$ 94.01KC$ 21.25K
Other Income Expense
--C$ -14.98KC$ 113.16KC$ 4.16KC$ -15.04K
Pretax Income
C$ -3.58MC$ -4.57MC$ -5.24MC$ -4.41MC$ -5.60MC$ -7.41M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -3.58MC$ -4.57MC$ -5.24MC$ -4.41MC$ -5.60MC$ -7.41M
Basic EPS
C$ -0.02C$ -0.02C$ -0.03C$ -0.02C$ -0.03C$ -0.05
Diluted EPS
C$ -0.02C$ -0.02C$ -0.03C$ -0.02C$ -0.03C$ -0.05
Basic Average Shares
C$ 653.49MC$ 219.97MC$ 207.92MC$ 204.28MC$ 204.28MC$ 144.68M
Diluted Average Shares
C$ 653.49MC$ 219.97MC$ 207.92MC$ 204.28MC$ 204.28MC$ 144.68M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----C$ 39.97KC$ 50.67K
Total Expenses
C$ 4.30M-C$ 6.37MC$ -5.32MC$ 6.63MC$ 8.38M
Net Income From Continuing And Discontinued Operation
C$ -3.58MC$ -4.57MC$ -5.24MC$ -4.41MC$ -5.60MC$ -7.41M
Normalized Income
C$ -2.63MC$ -3.36MC$ -3.85MC$ -3.37MC$ -5.60MC$ -7.40M
Interest Expense
----C$ 9.68KC$ 12.36K
EBIT
C$ -3.56MC$ -4.54MC$ -5.21MC$ -4.41MC$ -5.59MC$ -7.40M
EBITDA
C$ -3.34MC$ -4.25MC$ -4.90MC$ -4.13MC$ -5.32MC$ -7.15M
Currency in CAD

Theralase Technologies Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis